Evaluation of Ultrasonography in High Precision Radiotherapy of Cervical Cancers.
Phase 2
- Conditions
- Health Condition 1: null- Histologically proven Cervical Cancers suitable for Radical Radiation therapy with/ without concomitant chemotherapy and HDR brachytherapy.
- Registration Number
- CTRI/2013/12/004207
- Lead Sponsor
- Tata Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
Histologically proven Cervical Cancers suitable for Radical Radiation therapy with/without concomitant chemotherapy and HDR brachytherapy.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To establish utero-cervical and cervix including primary tumor movements during the course of EBRT. <br/ ><br>To establish Clincial Target Volume (CTV) and Internal Target Volume (ITV) margins for primary cervical tumor related target volume.Timepoint: 2 years
- Secondary Outcome Measures
Name Time Method S based Intracavitary brachytherapy planningTimepoint: 12 months
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does ultrasonography improve tumor visualization in cervical cancer HDR brachytherapy planning?
What are the comparative outcomes of ultrasonography vs. MRI in cervical cancer radiotherapy targeting?
Which biomarkers correlate with ultrasonography-guided radiotherapy response in histologically confirmed cervical cancers?
What adverse events are associated with ultrasonography-based cervical cancer radiotherapy and how are they mitigated?
How does integrating ultrasonography with HDR brachytherapy and chemotherapy affect cervical cancer treatment efficacy?